We look forward to supporting innovation in the life science industry by continuing to deliver effective risk transfer ...

The JADE study will be evaluating BI 1584862, an investigational oral compound that targets inflammation and preserves ...

Clinical Trials in India have gained global attention for their rapid growth, world-class infrastructure, and access to a diverse patient population. With increasing support from regulatory bodies and ...

researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

A potential game changer in the treatment of retinal disease, the novel dual-target drug shows encouraging results.

Inhibition of GSK-3β may inhibit tumor growth and improve survival through several complimentary mechanisms that include enhancement of chemotherapy activity, activation of innate anti-tumor immunity, ...

IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in women with advanced ovarian cancer Data from Phase 2 OVATION 2 Study are encouraging, ...

researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial operations ...